Loading…

Defining estimands in clinical trials: A unified procedure

The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regula...

Full description

Saved in:
Bibliographic Details
Published in:Statistics in medicine 2023-05, Vol.42 (12), p.1869-1887
Main Authors: Han, Shasha, Zhou, Xiao‐Hua
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703
cites cdi_FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703
container_end_page 1887
container_issue 12
container_start_page 1869
container_title Statistics in medicine
container_volume 42
creator Han, Shasha
Zhou, Xiao‐Hua
description The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regulators who interpret them. To improve the concordance, we provide a unified four‐step procedure for constructing the mathematical estimands. We apply the procedure for each strategy to derive the mathematical estimands and compare the five strategies in practical interpretations, data collection, and analytical methods. Finally, we show that the procedure can help ease tasks of defining estimands in settings with multiple types of intercurrent events using two real clinical trials.
doi_str_mv 10.1002/sim.9702
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2784839460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2814261914</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703</originalsourceid><addsrcrecordid>eNp1kMlKA0EQhhtRTIyCTyADXrxM7GV6mdxC3AIRD-q56W2kwyyxO4Pk7e2YqCB4Kqj6-KrqB-AcwTGCEF9H34xLDvEBGCJY8hxiKg7BEGLOc8YRHYCTGJcQIkQxPwYDwoQgjIghmNy4yre-fctcXPtGtTZmvs1MnZpG1dk6eFXHSTbN-tZX3tlsFTrjbB_cKTiq0syd7esIvN7dvswe8sXT_Xw2XeSGCIJzTLmjDGurhKiMIdQSYSBWxFqhCsNKrZ3ThGllMacUa6wpQbbUuOQOckhG4GrnTZvf-3SmbHw0rq5V67o-SsxFIUhZsC16-Qdddn1o03USC1RghkpU_ApN6GIMrpKrkF4PG4mg3OYpU55ym2dCL_bCXjfO_oDfASYg3wEfvnabf0Xyef74JfwEv8Z9Fw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2814261914</pqid></control><display><type>article</type><title>Defining estimands in clinical trials: A unified procedure</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Han, Shasha ; Zhou, Xiao‐Hua</creator><creatorcontrib>Han, Shasha ; Zhou, Xiao‐Hua</creatorcontrib><description>The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regulators who interpret them. To improve the concordance, we provide a unified four‐step procedure for constructing the mathematical estimands. We apply the procedure for each strategy to derive the mathematical estimands and compare the five strategies in practical interpretations, data collection, and analytical methods. Finally, we show that the procedure can help ease tasks of defining estimands in settings with multiple types of intercurrent events using two real clinical trials.</description><identifier>ISSN: 0277-6715</identifier><identifier>EISSN: 1097-0258</identifier><identifier>DOI: 10.1002/sim.9702</identifier><identifier>PMID: 36883638</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>causal inference ; clinical trials ; Data Collection ; Data Interpretation, Statistical ; estimands ; Humans ; intercurrent events ; Models, Statistical ; post‐treatment variables ; Research Design</subject><ispartof>Statistics in medicine, 2023-05, Vol.42 (12), p.1869-1887</ispartof><rights>2023 John Wiley &amp; Sons Ltd.</rights><rights>2023 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703</citedby><cites>FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703</cites><orcidid>0000-0001-7935-1222 ; 0000-0001-7388-8125</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36883638$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Shasha</creatorcontrib><creatorcontrib>Zhou, Xiao‐Hua</creatorcontrib><title>Defining estimands in clinical trials: A unified procedure</title><title>Statistics in medicine</title><addtitle>Stat Med</addtitle><description>The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regulators who interpret them. To improve the concordance, we provide a unified four‐step procedure for constructing the mathematical estimands. We apply the procedure for each strategy to derive the mathematical estimands and compare the five strategies in practical interpretations, data collection, and analytical methods. Finally, we show that the procedure can help ease tasks of defining estimands in settings with multiple types of intercurrent events using two real clinical trials.</description><subject>causal inference</subject><subject>clinical trials</subject><subject>Data Collection</subject><subject>Data Interpretation, Statistical</subject><subject>estimands</subject><subject>Humans</subject><subject>intercurrent events</subject><subject>Models, Statistical</subject><subject>post‐treatment variables</subject><subject>Research Design</subject><issn>0277-6715</issn><issn>1097-0258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp1kMlKA0EQhhtRTIyCTyADXrxM7GV6mdxC3AIRD-q56W2kwyyxO4Pk7e2YqCB4Kqj6-KrqB-AcwTGCEF9H34xLDvEBGCJY8hxiKg7BEGLOc8YRHYCTGJcQIkQxPwYDwoQgjIghmNy4yre-fctcXPtGtTZmvs1MnZpG1dk6eFXHSTbN-tZX3tlsFTrjbB_cKTiq0syd7esIvN7dvswe8sXT_Xw2XeSGCIJzTLmjDGurhKiMIdQSYSBWxFqhCsNKrZ3ThGllMacUa6wpQbbUuOQOckhG4GrnTZvf-3SmbHw0rq5V67o-SsxFIUhZsC16-Qdddn1o03USC1RghkpU_ApN6GIMrpKrkF4PG4mg3OYpU55ym2dCL_bCXjfO_oDfASYg3wEfvnabf0Xyef74JfwEv8Z9Fw</recordid><startdate>20230530</startdate><enddate>20230530</enddate><creator>Han, Shasha</creator><creator>Zhou, Xiao‐Hua</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7935-1222</orcidid><orcidid>https://orcid.org/0000-0001-7388-8125</orcidid></search><sort><creationdate>20230530</creationdate><title>Defining estimands in clinical trials: A unified procedure</title><author>Han, Shasha ; Zhou, Xiao‐Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>causal inference</topic><topic>clinical trials</topic><topic>Data Collection</topic><topic>Data Interpretation, Statistical</topic><topic>estimands</topic><topic>Humans</topic><topic>intercurrent events</topic><topic>Models, Statistical</topic><topic>post‐treatment variables</topic><topic>Research Design</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Han, Shasha</creatorcontrib><creatorcontrib>Zhou, Xiao‐Hua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Statistics in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Shasha</au><au>Zhou, Xiao‐Hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defining estimands in clinical trials: A unified procedure</atitle><jtitle>Statistics in medicine</jtitle><addtitle>Stat Med</addtitle><date>2023-05-30</date><risdate>2023</risdate><volume>42</volume><issue>12</issue><spage>1869</spage><epage>1887</epage><pages>1869-1887</pages><issn>0277-6715</issn><eissn>1097-0258</eissn><abstract>The ICH E9 (R1) addendum proposes five strategies to define estimands by addressing intercurrent events. However, mathematical forms of these targeted quantities are lacking, which might lead to discordance between statisticians who estimate these quantities and clinicians, drug sponsors, and regulators who interpret them. To improve the concordance, we provide a unified four‐step procedure for constructing the mathematical estimands. We apply the procedure for each strategy to derive the mathematical estimands and compare the five strategies in practical interpretations, data collection, and analytical methods. Finally, we show that the procedure can help ease tasks of defining estimands in settings with multiple types of intercurrent events using two real clinical trials.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>36883638</pmid><doi>10.1002/sim.9702</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0001-7935-1222</orcidid><orcidid>https://orcid.org/0000-0001-7388-8125</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0277-6715
ispartof Statistics in medicine, 2023-05, Vol.42 (12), p.1869-1887
issn 0277-6715
1097-0258
language eng
recordid cdi_proquest_miscellaneous_2784839460
source Wiley-Blackwell Read & Publish Collection
subjects causal inference
clinical trials
Data Collection
Data Interpretation, Statistical
estimands
Humans
intercurrent events
Models, Statistical
post‐treatment variables
Research Design
title Defining estimands in clinical trials: A unified procedure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A17%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defining%20estimands%20in%20clinical%20trials:%20A%20unified%20procedure&rft.jtitle=Statistics%20in%20medicine&rft.au=Han,%20Shasha&rft.date=2023-05-30&rft.volume=42&rft.issue=12&rft.spage=1869&rft.epage=1887&rft.pages=1869-1887&rft.issn=0277-6715&rft.eissn=1097-0258&rft_id=info:doi/10.1002/sim.9702&rft_dat=%3Cproquest_cross%3E2814261914%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3832-257e562bda88fcc35d38c02a3dd8a4c69bbeeb36bad27552b2b531d9b297e0703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2814261914&rft_id=info:pmid/36883638&rfr_iscdi=true